Maria E. Bennett

Maria E. Bennett has led SPR Therapeutics since its inception. Prior to the formation of SPR, Maria Bennett served as the VP of Clinical Affairs at NDI Medical, LLC a medical device development company where she played a vital role in the development of a neurostimulation system addressing urinary incontinence, which was acquired by Medtronic in 2008 company for $42 million. Prior to joining NDI, Maria Bennett was a Clinical Project Manager at Boston Scientific, leading a team that conducted a large, multi-center clinical trial demonstrating the safety and efficacy of an innovative angioplasty balloon and achieving a 510(k) clearance for this product.